SCHEMBL1826892

SCHEMBL1826892

COC(C)c1cccc(OS(=O)(=O)c2ccc(C)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
LMNA P02545 2/20 0.46
HPGD P15428 2/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MAOB P27338 1/20 0.45
MAPT P10636 5/20 0.44
HTT P42858 4/20 0.44
L3MBTL1 Q9Y468 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
GPR17 Q13304 1/20 0.43
GAA P10253 3/20 0.42
G6PD P11413 1/20 0.42
DRD2 P14416 1/20 0.42
DRD1 P21728 1/20 0.42
DRD4 P21917 1/20 0.42
DRD5 P21918 1/20 0.42
DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1825480 0.89 ALDH1A1 (0.48) ALDH1A1LMNAMAOBMAPTHTT
SCHEMBL1825360 0.85 ALDH1A1 (0.46) ALDH1A1LMNAHPGDMEN1KMT2A
SCHEMBL3573281 0.85 ACHE (0.50) ALDH1A1LMNAHPGDMEN1KMT2A
SCHEMBL1823209 0.84 MEN1 (0.50) ALDH1A1LMNAHPGDMEN1KMT2A
SCHEMBL1825096 0.84 KMT2A (0.45) ALDH1A1LMNAHPGDMEN1KMT2A
SCHEMBL1825788 0.83 ALDH1A1 (0.47) ALDH1A1LMNAHPGDMEN1KMT2A
SCHEMBL1827991 0.82 MEN1 (0.58) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL2838551 0.82 ALDH1A1 (0.48) ALDH1A1LMNAHPGDMEN1KMT2A
SCHEMBL1824909 0.82 GPR17 (0.47) ALDH1A1LMNAHPGDMEN1KMT2A
SCHEMBL1824278 0.82 ALDH1A1 (0.44) ALDH1A1LMNAHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 ALDH1A1 1099/4885LMNA 1802/4885HPGD 4329/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 ALDH1A1 1440/4885LMNA 1130/4885HPGD 3801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.